Supernus Pharmaceuticals | SUPN - Passifs Courants





Passifs Courants Changement Date
Abbott USD 18.38B 1.88B 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Canopy Growth CAD 98.29M 17.19M 2025-12
Cara Therapeutics USD 11.04M 2K 2025-12
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Eisai JPY 340.25B 47.42B 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Novo Nordisk DKK 225.16B 9.5B 2026-03
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03